Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I had many questions about NPS. KSquare cleared every doubt and gave me a structured plan to follow.
The NFO section on KSquare is so well designed. I love the simplified jargon and timely alerts before each launch. Great for busy professionals!
KSquare’s New Fund Offering system is reliable and easy to follow. Their pre-launch alerts and fund guides helped me confidently choose what’s best for me.
KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.
Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.
KSquare’s SIP has brought structure to my investment plan. It's great for disciplined investing, and the automation ensures I never miss a payment. Very happy with the service so far!
I’m very happy with the NPS service at KSquare. Their personalized advice gave me the clarity I needed.
KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.
Thanks to KSquare, I started my investment journey the right way. Their mutual fund options are diverse, affordable, and super easy to manage.
Managing money in India while living overseas used to be stressful. KSquare’s platform made everything manageable and safe.
FAQ's
Frequenlty Asked Question
Can I use LAMF for personal or business purposes?
Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.
Will I still earn returns on pledged mutual funds?
Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.
What is the role of the AMC in a New Fund Offering?
The Asset Management Company (AMC) designs and manages the NFO, ensuring strategy alignment and regulatory compliance.
How does KSquare help with mutual fund selection?
KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.
Do NFOs offer better returns than existing funds?
Not always. While some NFOs may perform well, they lack historical data. KSquare helps evaluate the potential.
What if I fail to repay the loan on time?
In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.
Can I nominate someone for my NPS account?
Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.
Is the loan process fully online at KSquare?
Yes, KSquare offers a completely paperless experience with online verification and fast approval.